These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18496183)

  • 21. Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study.
    Skolnick BE; Shenouda M; Khutoryansky NM; Pusateri AE; Gabriel D; Carr ME
    Anesth Analg; 2011 Oct; 113(4):703-10. PubMed ID: 21890888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progression of traumatic intracerebral hemorrhage: a prospective observational study.
    Narayan RK; Maas AI; Servadei F; Skolnick BE; Tillinger MN; Marshall LF;
    J Neurotrauma; 2008 Jun; 25(6):629-39. PubMed ID: 18491950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Recombinant Activated Coagulation Factor VII on Hemorrhage Expansion Among Patients With Spot Sign-Positive Acute Intracerebral Hemorrhage: The SPOTLIGHT and STOP-IT Randomized Clinical Trials.
    Gladstone DJ; Aviv RI; Demchuk AM; Hill MD; Thorpe KE; Khoury JC; Sucharew HJ; Al-Ajlan F; Butcher K; Dowlatshahi D; Gubitz G; De Masi S; Hall J; Gregg D; Mamdani M; Shamy M; Swartz RH; Del Campo CM; Cucchiara B; Panagos P; Goldstein JN; Carrozzella J; Jauch EC; Broderick JP; Flaherty ML;
    JAMA Neurol; 2019 Dec; 76(12):1493-1501. PubMed ID: 31424491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant factor VIIa plus surgery for intracerebral hemorrhage.
    Sutherland CS; Hill MD; Kaufmann AM; Silvaggio JA; Demchuk AM; Sutherland GR
    Can J Neurol Sci; 2008 Nov; 35(5):567-72. PubMed ID: 19235439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant factor VIIa treatment of severe bleeding in cardiac surgery patients: a retrospective analysis of dosing, efficacy, and safety outcomes.
    Masud F; Bostan F; Chi E; Pass SE; Samir H; Stuebing K; Liebl MG
    J Cardiothorac Vasc Anesth; 2009 Feb; 23(1):28-33. PubMed ID: 18948033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII.
    Steiner T; Diringer MN; Schneider D; Mayer SA; Begtrup K; Broderick J; Skolnick BE; Davis SM
    Neurosurgery; 2006 Oct; 59(4):767-73; discussion 773-4. PubMed ID: 17038942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage.
    Freeman WD; Brott TG; Barrett KM; Castillo PR; Deen HG; Czervionke LF; Meschia JF
    Mayo Clin Proc; 2004 Dec; 79(12):1495-500. PubMed ID: 15595332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant coagulation factor VIIa in major liver resection: a randomized, placebo-controlled, double-blind clinical trial.
    Lodge JP; Jonas S; Oussoultzoglou E; Malagó M; Jayr C; Cherqui D; Anthuber M; Mirza DF; Kuhlman L; Bechstein WO; Díaz JC; Tartiere J; Eyraud D; Fridberg M; Erhardtsen E; Mimoz O
    Anesthesiology; 2005 Feb; 102(2):269-75. PubMed ID: 15681939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multicenter assessment of recombinant factor VIIa off-label usage: clinical experiences and associated outcomes.
    MacLaren R; Weber LA; Brake H; Gardner MA; Tanzi M
    Transfusion; 2005 Sep; 45(9):1434-42. PubMed ID: 16131375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single 270 microg kg(-1)-dose rFVIIa vs. standard 90 microg kg(-1)-dose rFVIIa and APCC for home treatment of joint bleeds in haemophilia patients with inhibitors: a randomized comparison.
    Young G; Shafer FE; Rojas P; Seremetis S
    Haemophilia; 2008 Mar; 14(2):287-94. PubMed ID: 18081834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of recombinant activated factor VII concentrate to control postoperative hemorrhage in complex cardiovascular surgery.
    Bowman LJ; Uber WE; Stroud MR; Christiansen LR; Lazarchick J; Crumbley AJ; Kratz JM; Toole JM; Crawford FA; Ikonomidis JS
    Ann Thorac Surg; 2008 May; 85(5):1669-76; discussion 1676-7. PubMed ID: 18442563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry.
    Parameswaran R; Shapiro AD; Gill JC; Kessler CM;
    Haemophilia; 2005 Mar; 11(2):100-6. PubMed ID: 15810910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of recombinant activated factor VII in traumatic nonsurgical intracranial hemorrhage.
    White CE; Schrank AE; Baskin TW; Holcomb JB
    Curr Surg; 2006; 63(5):310-7. PubMed ID: 16971200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical trial to investigate the pharmacokinetics, pharmacodynamics, safety, and efficacy of recombinant factor VIIa in Japanese patients with hemophilia with inhibitors.
    Shirahata A; Kamiya T; Takamatsu J; Kojima T; Fukutake K; Arai M; Hanabusa H; Tagami H; Yoshioka A; Shima GM; Naka GH; Fujita GS; Minamoto Y; Kamizono J; Saito H
    Int J Hematol; 2001 Jun; 73(4):517-25. PubMed ID: 11503968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A meta-analysis of the efficacy and safety of recombinant activated factor VII for patients with acute intracerebral hemorrhage without hemophilia.
    Yuan ZH; Jiang JK; Huang WD; Pan J; Zhu JY; Wang JZ
    J Clin Neurosci; 2010 Jun; 17(6):685-93. PubMed ID: 20399668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial.
    Bosch J; Thabut D; Bendtsen F; D'Amico G; Albillos A; González Abraldes J; Fabricius S; Erhardtsen E; de Franchis R;
    Gastroenterology; 2004 Oct; 127(4):1123-30. PubMed ID: 15480990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of recombinant activated factor VII for refractory hemorrhage in pediatric patients on extracorporeal membrane oxygenation: a single center review.
    Long MT; Wagner D; Maslach-Hubbard A; Pasko DA; Baldridge P; Annich GM
    Perfusion; 2014 Mar; 29(2):163-70. PubMed ID: 23942787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The treatment of bleeding is to stop the bleeding! Treatment of trauma-related hemorrhage.
    Boffard KD; Choong PI; Kluger Y; Riou B; Rizoli SB; Rossaint R; Warren B;
    Transfusion; 2009 Dec; 49 Suppl 5():240S-7S. PubMed ID: 19954486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dosing, efficacy, and safety of recombinant factor VIIa (rFVIIa) in pediatric versus adult patients: the experience of the Hemostasis and Thrombosis Research Society (HTRS) Registry (2004-2008).
    Neufeld EJ; Saxena K; Kessler CM; Cooper DL;
    Pediatr Blood Cancer; 2013 Jul; 60(7):1178-83. PubMed ID: 23335449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single higher dose of recombinant activated factor VII in the treatment of hemorrhages in patients with hemophilia complicated by inhibitors.
    Łaguna P; Mital A
    Adv Clin Exp Med; 2012; 21(4):519-24. PubMed ID: 23240458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.